Literature DB >> 11783765

The choice of dialysis solutions in pediatric chronic peritoneal dialysis: guidelines by an ad hoc European committee.

C H Schröder1.   

Abstract

OBJECTIVE: To provide guidelines on choosing dialysis solutions for children on chronic peritoneal dialysis (PD).
SETTING: European Paediatric Peritoneal Dialysis Working Group. DATA SOURCE: Literature on the application of PD solutions in children (Evidence), and discussions within the group (Opinion).
CONCLUSIONS: Glucose is the standard osmotic agent for PD in children (Evidence). The lowest glucose concentration needed should be used (Opinion). Low calcium solution (1.25 mmol/L) should be applied, wherever possible, with careful monitoring of parathyroid hormone levels (Opinion). The use of amino acid-containing dialysis fluids can be considered in malnourished children, although aggressive enteral nutrition is preferred (Opinion). There is insufficient evidence documenting the efficacy of intraperitoneally administered amino acids (Evidence). When ultrafiltration and/or solute removal are insufficient, polyglucose solutions are a welcome addition to the treatment of children on nocturnal intermittent PD (Evidence). However, in the absence of any reported long-term experience with children, their use must be closely monitored (Opinion). Bicarbonate would appear to be the preferred buffer for PD in children, but more in vivo studies are required before it replaces the present lactate-containing solutions (Evidence/Opinion).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11783765

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  11 in total

Review 1.  New peritoneal dialysis fluids: practical use for children.

Authors:  Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2003-11       Impact factor: 3.714

Review 2.  Clinical practice guidelines for pediatric peritoneal dialysis.

Authors:  Colin T White; Manjula Gowrishankar; Janusz Feber; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

3.  Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group.

Authors:  Claus Peter Schmitt; Sevcan A Bakkaloglu; Günter Klaus; Cornelis Schröder; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2011-03-31       Impact factor: 3.714

Review 4.  Glycation free adduct accumulation in renal disease: the new AGE.

Authors:  Paul J Thornalley
Journal:  Pediatr Nephrol       Date:  2005-08-24       Impact factor: 3.714

5.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

Review 6.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis.

Authors:  Thorsten O Bender; Janusz Witowski; Christoph Aufricht; Michaela Endemann; Ulrich Frei; Jutta Passlick-Deetjen; Achim Jörres
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

8.  Paediatric acute peritoneal dialysis in southern Nigeria.

Authors:  I C Anochie; F U Eke
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

Review 9.  Selection of modalities, prescription, and technical issues in children on peritoneal dialysis.

Authors:  Enrico Verrina; Valeria Cappelli; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2008-06-03       Impact factor: 3.714

10.  Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

Authors:  G Klaus; A Watson; A Edefonti; M Fischbach; K Rönnholm; F Schaefer; E Simkova; C J Stefanidis; V Strazdins; J Vande Walle; C Schröder; A Zurowska; M Ekim
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.